|
Video: What is a Stock Split?
|
|
Bluejay Diagnostics is a late-stage company focused on improving patient outcomes through a near patient product for triage, diagnosis and monitoring of disease progression. Co.'s diagnostic system, which Co. refers to as Symphony, which is an automated diagnostic system, consisting of a fluorescence immuno-analyzer which uses a single-use diagnostic test cartridge with reagents integrated into the cartridge. Symphony utilizes a sample-to-result format, which means that once a specimen is taken from the patient, it is placed in the cartridge and then the cartridge is placed inside the analyzer where the test is run without further technician intervention or additional reagent. According to our BJDX split history records, Bluejay Diagnostics has had 1 split. | |
|
Bluejay Diagnostics (BJDX) has 1 split in our BJDX split history database. The split for BJDX took place on July 24, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of BJDX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as Bluejay Diagnostics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the BJDX split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bluejay Diagnostics shares, starting with a $10,000 purchase of BJDX, presented on a split-history-adjusted basis factoring in the complete BJDX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/11/2021 |
|
End date: |
05/01/2024 |
|
Start price/share: |
$98.40 |
|
End price/share: |
$0.54 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.46% |
|
Average Annual Total Return: |
-87.90% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$54.43 |
|
Years: |
2.47 |
|
|
|
Date |
Ratio |
07/24/2023 | 1 for 20 |
|
|